Delving into the Latest Updates on Nitto Avecia Pharma Services, Inc. with Synapse

Overview

Tags

Respiratory Diseases

Infectious Diseases

Fusion protein

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Infectious Diseases	1

Top 5 Drug Type	Count

Fusion protein	1

Top 5 Target	Count

sialic acid	1

Primary objectives: To investigate the efficacy of DAS181 in the treatment of severe hospitalized IFV and non-IFV SAD-RV virus-infected subjects. To determine the dose of DAS181 for the treatment of severe hospitalized IFV. Secondary objectives: To evaluate the tolerability, pharmacokinetics, and immunogenicity of DAS181 in the treatment of severe hospitalized IFV-infected subjects.

Start Date-

Sponsor / Collaborator

Nitto Avecia Pharma Services, Inc.

[+3]

CTR20210106 / Active, not recruitingPhase 3

一项评估曲安奈德脉络膜上腔注射混悬液（ARVN001）治疗继发于非感染性葡萄膜炎的黄斑水肿的有效性和安全性的随机、双盲、假注射对照、多中心III期研究

[Translation] A randomized, double-blind, sham-controlled, multicenter phase III study to evaluate the efficacy and safety of triamcinolone acetonide suprachoroidal injection suspension (ARVN001) in the treatment of macular edema secondary to non-infectious uveitis

评价ARVN001脉络膜上腔注射液在继发于非感染性葡萄膜炎的黄斑水肿受试者中的安全性和有效性

[Translation]

To evaluate the safety and efficacy of ARVN001 suprachoroidal injection in subjects with macular edema secondary to non-infectious uveitis

Start Date02 Nov 2021

Sponsor / Collaborator

Nitto Avecia Pharma Services, Inc.

[+2]

100 Clinical Results associated with Nitto Avecia Pharma Services, Inc.

Login to view more data

0 Patents (Medical) associated with Nitto Avecia Pharma Services, Inc.

Login to view more data

100 Deals associated with Nitto Avecia Pharma Services, Inc.

Login to view more data

100 Translational Medicine associated with Nitto Avecia Pharma Services, Inc.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 2 Clinical

1

Login to view more data